There are silver linings I suppose to Medipharm's PPS. My shares are stuck. Can't inject any more to further reduce my cost basis without "signs-of-life".
Medipharm just looks dead in the water until they get more EU approvals. That could take another 6 - 12 months, if ever.
Expect another capital raise before then to keep the lights on. That's the definition of "bad dilution".
New money on dips at the other extractor is the better play.